Clinical Trials Browser

Phase 1/2 × Suspended × Fluorodeoxyglucose F18 × Clear all

NCT02130492 2025-10-23

A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)

Phase 1/2 Suspended

Neoplasms